Gentiva Health Services Shares Plunged: What You Need to Know

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of home-health-care specialist Gentiva Health Services (Nasdaq: GTIV  ) are nose-diving 16% today following reports that Congress has apparently reached a deal to avert the looming debt-ceiling crisis.

So what: The worry is that the outlined debt-reduction package is going to sack the health-care sector, including home-health-care providers. Social Security, Medicaid, and veterans' benefits are protected from automatic reductions, but companies that receive payments from Medicare could be facing a serious pinch later this year when payments would be scheduled to drop by 11%. Gentiva is one of those companies, along with myriad other health-care companies taking it on the chin today.

Now what: I don't feel it's ever too early to be skeptical about a stock, but short-sellers may be jumping the gun on a relatively well-run company. Again, we have a lot of unanswered questions as to exactly how much we might see in spending cutbacks for Medicare, but Gentiva's forward P/E of 5.6, and the fact that it now trades well below its book value, makes it an attractive company to watch. With larger rival Amedisys (Nasdaq: AMED  ) also valued at just 8.3 times forward earnings, this could be a seriously undervalued sector.

Craving more input? Add Gentiva Health Services to your watchlist!

Fool contributor Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1530030, ~/Articles/ArticleHandler.aspx, 10/22/2016 5:59:23 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 20 hours ago Sponsored by:
DOW 18,145.71 -16.64 -0.09%
S&P 500 2,141.16 -0.18 -0.01%
NASD 5,257.40 15.57 0.30%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
GTIV.DL $0.00 Down +0.00 +0.00%
Gentiva Health Ser… CAPS Rating: **
AMED $43.86 Down -1.29 -2.86%
Amedisys CAPS Rating: **